(Q69372719)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

title

Complement activation and high-dose of interleukin-2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

author name string

L G Thijs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

C E Hack

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

R J Strack van Schijndel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

J H Nuijens

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

G J Wolbink

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

A J Eerenberg-Belmer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

H van der Vall

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

language of work or name

English

0 references

publication date

1 August 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

issue

8659

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

page(s)

395

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.

1 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990577-1

7 January 2021

Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990577-1

7 January 2021

Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990577-1

7 January 2021

Structure and function of the anaphylatoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990577-1

7 January 2021

10.1016/S0140-6736(89)90577-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569587%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

1 reference